Concomitant medication among persistent opioid users with chronic non-malignant pain

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 10, 2012, Pages 1267-1276

  Mellbye, A ^a,b   Svendsen, K ^a,b   Borchgrevink, P C ^a,b   Skurtveit, S ^c,d   Fredheim, O M S ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DATA BASE; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZODIAZEPINES; CHRONIC PAIN; DATABASES, FACTUAL; DRUG UTILIZATION; HUMANS; HYPNOTICS AND SEDATIVES; NORWAY; SEROTONIN UPTAKE INHIBITORS;

EID: 84867576411     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02766.x     Document Type: Article

References (29)

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D,. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287-333.
2. Fishbain DADA,. Polypharmacy treatment approaches to the psychiatric and somatic comorbidities found in patients with chronic pain. Am J Phys Med Rehabil 2005; 84: S56-S63.
3. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T,. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-1188.
4. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD,. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-14.
5. Lin EHB, Katon W, Von Korff M, Tang L, Williams JW, Kroenke K, Hunkeler E, Harpole L, Hegel M, Arean P, Hoffing M, Della Penna R, Langston C, Unützer C,. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003; 290: 2428-2429.
6. Ambrosio F, Finco G, Mattia C, Mediati R, Paoletti F, Coluzzi F, Piacevoli Q, Savoia G, Amantea B, Aurilio C, Bonezzi C, Camaioni D, Chiefari M, Costantini A, Evangelista M, Ischia S, Mondello E, Polati E, Raffaeli W, Sabato AF, Varrassi G, Visentin M, Tufano R,. SIAARTI recommendations for chronic noncancer pain. Minerva Anestesiol 2006; 72: 859-880.
7. Dellemijn PL, Fields HL,. Do benzodiazepines have a role in chronic pain management? Pain 1994; 57: 137-152.
8. Furlan AD, Reardon R, Weppler C,. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 2010; 182: 923-930.
9. Norwegian Medicines Agency. Terapianbefaling: bruk av opioider ved langvarige, non-maligne smertetilstander-en oppdatering. Norwegian Medicines Agency 2008; www.legemiddelverket.no/upload/Terapianbefaling-bruk av opioder.pdf. Accessed 17.08.2012.
10. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L,. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11: S5-S62.
11. Højsted J, Nielsen PR, Guldstrand SK, Frich L, Sjøgren P,. Classification and identification of opioid addiction in chronic pain patients. Eur J Pain 2010; 14: 1014-1020.
12. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C,. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18: 1166-1175.
13. Pauly V, Frauger E, Pradel V, Rouby F, Berbis J, Natali F, Reggio P, Coudert H, Micallef J, Thirion X,. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling high dosage buprenorphine abuse. Drug Alcohol Depend 2011; 113: 29-36.
14. Skurtveit S, Furu K, Bramness JG, Selmer R, Tverdal A,. Benzodiazepines predict use of opioids-a follow-up study of 17,074 men and women. Pain Med 2010; 11: 805-814.
15. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD,. EFNS guidelines on neuropathic pain assessment: revised. Eur J Neurol 2009; 2010: 1010-1018.
16. Raskin J, Smith TR, Wong K, Pritchett YL, D'Souza DN, Iyengar S, Wernicke JF,. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 2006; 9: 29-40.
17. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK,. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006; 125: 172-179.
18. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT,. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010; 106: 86-94.
19. WHO Collaborating Center for Drugs Statistics Methodology. ATC Classification Index with DDDs. World Health Organization 2012; http://www.whocc.no/atc-ddd-index/. Accessed 17.08.2012.
20. Caetano PA, Lam JM, Morgan SG,. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006; 28: 1411-1424.
21. Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OMS,. Differential patterns of opioid use: defining persistent opioid use in a prescription database. Eur J Pain 2012; 16: 359-369.
22. Svendsen K, Borchgrevink PC, Fredheim O, Hamunen K, Mellbye A, Dale O,. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med 2011; 25: 725-732.
23. Tobi H, Faber A, van den, Berg PB, Drane JW, de Jong-van den Berg LT,. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 2007; 16: 405-411.
24. Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim OMS,. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain 2011; 152: 1555-1561.
25. Fredheim OMS, Kaasa S, Fayers P, Saltnes T, Jordhøy M, Borchgrevink PC,. Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients. Acta Anaesthesiol Scand 2008; 52: 143-148.
26. Becker N, Bondegaard Thomsen A, Olsen AK, Sjogren P, Bech P, Eriksen J,. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997; 73: 393-400.
27. Bair MJ, Robinson RL, Katon W, Kroenke K,. Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163: 2433-2445.
28. Moulin DE, Clark AJ, Gilron I, Ware M, Watson CPN, Sessle BJ, Coderre T, Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman GB, Velly AL,. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007; 12: 13-21.
29. Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell A,. Prevalence and characteristics of opioid use in the US adult population. Pain 2008; 138: 507-513.